CRISPR Therapeutics rose in premarket trading after J.P. Morgan initiated coverage with an Overweight rating and a $70 price target.

#CRSP #CRSPStock #CRISPRTherapeutics #CRSPNews #CRSPStockNews #CRISPRTherapeuticsStock #CRISPRTherapeuticsNews #CRISPRTherapeuticsStockNews #GeneEditing #Biotech
CRSP

Vertex Secures NHS Reimbursement for Casgevy in Sickle Cell Treatment

Video: youtube.com/shorts/foMlu...

#CRSP #VRTX #CRSPStock #VRTXStock #CRSPNews #CRSPStockNews #VRTXNews #VRTXStockNews #Casgevy #CasgevyUK #CRISPRUK #CRISPR #CRISPRTherapeutics #CRISPRTherapeuticsStock
$CRSP $VRTX

Gene editing stocks surged after Bloomberg reported the FDA plans to streamline approvals for gene editing therapies.

#CRSP #CRSPStock #CRISPR #CRSPNews #CRSPStockNews #CRISPRTherapeuticsStock #CRISPRStock #GeneEditing #Biotech #GeneTherapy #FDA #DrugApproval #Editas #Intellia
$CRSP